• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Mark Josephson and the ICD: A Personal Perspective.马克·约瑟夫森与国际疾病分类（ICD）：个人视角
Arrhythm Electrophysiol Rev. 2017 Apr;6(1):19-20. doi: 10.15420/aer.2017.6.1:PP8.
2
Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients.透析患者中植入式心脏转复除颤器的预防性应用预防心源性猝死。
Circulation. 2019 Jun 4;139(23):2628-2638. doi: 10.1161/CIRCULATIONAHA.119.039818. Epub 2019 Mar 18.
3
[Sudden cardiac death in the youth. Is the new subcutaneous implantable cardioverter defibrillator S-ICD an alternative solution?].[青年心脏性猝死。新型皮下植入式心律转复除颤器S-ICD是一种替代解决方案吗？]
Ann Cardiol Angeiol (Paris). 2015 Feb;64(1):27-31. doi: 10.1016/j.ancard.2014.08.018. Epub 2014 Sep 18.
4
Implantable cardioverter defibrillator for prevention of sudden cardiac death in patients with ventricular tachycardia and ventricular fibrillation: ICD therapy in sudden cardiac death.植入式心脏复律除颤器用于预防室性心动过速和心室颤动患者的心源性猝死：心源性猝死中的植入式心脏复律除颤器治疗
Pacing Clin Electrophysiol. 1993 Mar;16(3 Pt 2):511-8. doi: 10.1111/j.1540-8159.1993.tb01618.x.
5
SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.心脏性猝死-心力衰竭试验（SCD-HeFT）：利用R-R间期统计数据进行心律失常性心脏性猝死的长期风险分层。
Heart Rhythm. 2015 Oct;12(10):2058-66. doi: 10.1016/j.hrthm.2015.06.030. Epub 2015 Jun 19.
6
Polish single-centre follow-up of subcutaneous implantable cardioverter-defibrillator (S-ICD) systems implanted for the prevention of sudden cardiac death.波兰单中心皮下植入式心律转复除颤器（S-ICD）系统植入预防心源性猝死的随访研究。
Kardiol Pol. 2018;76(2):452-458. doi: 10.5603/KP.a2017.0244. Epub 2018 Jan 19.
7
Survival After Secondary Prevention Implantable Cardioverter-Defibrillator Placement: An Analysis From the NCDR ICD Registry.二次预防植入式心脏复律除颤器置入后的生存情况：来自 NCDR ICD 注册中心的分析。
JACC Clin Electrophysiol. 2017 Jan;3(1):20-28. doi: 10.1016/j.jacep.2016.06.001. Epub 2016 Sep 7.
8
Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.慢性完全性冠状动脉闭塞对缺血性二级预防植入式心脏复律除颤器受者室性心律失常复发的影响（VACTO 二级研究）：来自冠状动脉造影和电图分析的见解。
JACC Cardiovasc Interv. 2017 May 8;10(9):879-888. doi: 10.1016/j.jcin.2017.02.008.
9
Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).使用 6 分钟步行距离来确定植入式心脏复律除颤器和胺碘酮治疗效果的差异：来自 SCD-HeFT（心力衰竭中的心脏性猝死试验）的结果。
J Am Coll Cardiol. 2014 Jun 17;63(23):2560-2568. doi: 10.1016/j.jacc.2014.02.602. Epub 2014 Apr 9.
10
Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator.使用可穿戴式心脏复律除颤器移除植入式心脏复律除颤器（ICD）后预防门诊患者心源性猝死
Pacing Clin Electrophysiol. 2014 May;37(5):562-8. doi: 10.1111/pace.12319. Epub 2013 Dec 3.

本文引用的文献

1
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure.非缺血性收缩性心力衰竭患者的除颤器植入
N Engl J Med. 2016 Sep 29;375(13):1221-30. doi: 10.1056/NEJMoa1608029. Epub 2016 Aug 27.
2
A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.对植入式心脏复律除颤器预防心源性猝死治疗的批判性评价。
J Am Coll Cardiol. 2008 Sep 30;52(14):1111-21. doi: 10.1016/j.jacc.2008.05.058.
3
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.《美国心脏病学会/美国心脏协会/心律学会2008年心脏节律异常器械治疗指南》：美国心脏病学会/美国心脏协会实践指南工作组（修订ACC/AHA/NASPE 2002年心脏起搏器和抗心律失常器械植入指南更新的写作委员会）报告：与美国胸外科协会和胸外科医师学会合作制定。
Circulation. 2008 May 27;117(21):e350-408. doi: 10.1161/CIRCUALTIONAHA.108.189742. Epub 2008 May 15.
4
All patients with hemodynamically tolerated postinfarction ventricular tachycardia do not require an implantable cardioverter-defibrillator.所有血流动力学耐受的心肌梗死后室性心动过速患者并不都需要植入式心脏复律除颤器。
Circulation. 2007 Sep 4;116(10):1204-12. doi: 10.1161/CIRCULATIONAHA.106.670067.
5
Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?植入式心脏复律除颤器治疗的频率及原因：器械治疗会促发心律失常吗？
Am J Cardiol. 2006 Apr 15;97(8):1255-61. doi: 10.1016/j.amjcard.2005.11.048. Epub 2006 Mar 9.
6
The role of the implantable cardioverter-defibrillator for prevention of sudden cardiac death.
Ann Intern Med. 2000 Dec 5;133(11):901-10. doi: 10.7326/0003-4819-133-11-200012050-00015.
7
A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.一项关于冠心病患者猝死预防的随机研究。多中心非持续性心动过速试验研究人员。
N Engl J Med. 1999 Dec 16;341(25):1882-90. doi: 10.1056/NEJM199912163412503.
8
Relation of induced to spontaneous ventricular tachycardia from analysis of stored far-field implantable defibrillator electrograms.通过对植入式除颤器存储的远场心电图分析，探讨诱发性室性心动过速与自发性室性心动过速的关系。
Am J Cardiol. 1999 Feb 1;83(3):349-53. doi: 10.1016/s0002-9149(98)00867-4.
9
The automatic implantable cardioverter-defibrillator: efficacy, complications, and device failures.
Ann Intern Med. 1986 Apr;104(4):481-8. doi: 10.7326/0003-4819-104-4-481.
10
Use of the automatic implantable cardioverter-defibrillator.植入式自动心脏复律除颤器的使用。
N Engl J Med. 1986 Jul 3;315(1):63-4. doi: 10.1056/NEJM198607033150113.

马克·约瑟夫森与国际疾病分类（ICD）：个人视角

Mark Josephson and the ICD: A Personal Perspective.

作者信息

Swerdlow Charles D

机构信息

Cedars-Sinai Medical Center, Los Angeles, USA.

出版信息

Arrhythm Electrophysiol Rev. 2017 Apr;6(1):19-20. doi: 10.15420/aer.2017.6.1:PP8.

DOI:10.15420/aer.2017.6.1:PP8
PMID:28507741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5430926/
Abstract

Mark Josephson dedicated his career to the prevention of premature sudden cardiac death (SCD). Toward that goal, he was an early adopter of the implantable cardioverter defibrillator (ICD) and indefatigable advocate for better ICD technology,[1] both as a clinical tool and as living laboratory to study SCD in ambulatory patients. With characteristic intellectual integrity and analytical rigour, he sought an honest and balanced appraisal of the life-saving benefits and serious complications of this unique therapy.

摘要

马克·约瑟夫森将他的职业生涯奉献给了预防过早心脏性猝死（SCD）。为了实现这一目标，他是植入式心脏复律除颤器（ICD）的早期使用者，也是更好的ICD技术的不懈倡导者，[1] 既将其作为一种临床工具，也作为研究门诊患者SCD的活体实验室。凭借其特有的知识完整性和分析严谨性，他寻求对这种独特疗法的救命益处和严重并发症进行诚实而平衡的评估。